Clinical Trial Update: A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating MK-2828 in people with kidney disease, including chronic kidney disease and end-stage renal disease, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• MK-2828

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Kidney Failure, End-Stage Renal Disease | Phase 1 | Status: RECRUITING